UAB will build an autonomous vehicle mobility facility that works in collaboration with its Engineering and Innovative Technology Development research group.
Integration of the telehealth platform in a multiphase optimization strategy evaluation will allow researchers to develop behavioral health approaches that are more realistic and tailored to the individual’s goals and health needs.
The vaccine candidate Altimmune’s AdCOVID potently stimulated neutralizing antibody and T cell responses, as well as mucosal immunity in the respiratory tract.
Precision disease modeling involves creation of patient-specific disease models that mimic the molecular character of a condition present in a patient, enabling more precise diagnoses and treatments.
The exosomes were secreted by cardiac cells derived from human induced pluripotent stem cells. These non-living exosomes may be an easier form of regenerative treatment than living cells.
The UAB Nathan Shock Center received a $4.5 million grant renewal from the National Institute on Aging to further engage in cutting-edge research focused on comparative bioenergetics and aging.
This study of ischemic stroke patients is the first to associate the neutrophil-lymphocyte ratio in patients with COVID-19 and ischemic stroke and stroke severity.
A study conducted by UAB investigators has outlined that Black individuals with heart failure have a worse prognosis, even after achieving biomarker-based heart failure treatment targets.
Failing to account for weaker firearm laws in neighboring states made it falsely appear that a states’ laws were about 20 percent less effective in reducing firearm deaths.
In a new trial funded through UAB’s urgent COVID-19 research program, investigators are comparing the widely available steroid methylprednisolone with dexamethasone, which lowered risk of dying by one-third in a U.K. trial this summer.
A drug that inhibits the protease plasmin is hypothesized to reduce the infectivity and virulence of the virus, as measured by reduced need for hospitalization within a week.
Drs. Vickers and Pisu will use a $3 million, five-year National Institute on Minority Health and Health Disparities grant to study barriers that may exist for GI cancer patients to access quality cancer surgery in Alabama and Mississippi.
UAB is an Equal Opportunity/Affirmative Action Employer committed to fostering a diverse, equitable and family-friendly environment in which all faculty and staff can excel and achieve work/life balance irrespective of race, national origin, age, genetic or family medical history, gender, faith, gender identity and expression as well as sexual orientation. UAB also encourages applications from individuals with disabilities and veterans.